Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Evelo Biosciences, Inc. | d570224dex322.htm |
| EX-31.2 - EX-31.2 - Evelo Biosciences, Inc. | d570224dex312.htm |
| EX-31.1 - EX-31.1 - Evelo Biosciences, Inc. | d570224dex311.htm |
| 10-Q - 10-Q - Evelo Biosciences, Inc. | d570224d10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Balkrishan (Simba) Gill, Ph.D., President and Chief Executive Officer of Evelo Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
| (1) | The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2018 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: May 31, 2018 | By: | /s/ Balkrishan (Simba) Gill, Ph.D. | ||||
| Balkrishan (Simba) Gill, Ph.D. | ||||||
| President and Chief Executive Officer | ||||||
| (Principal Executive Officer) |